PHASTAR Names Chris Schoonmaker as Chief Operations Officer
London, UK and Durham, NC – June 29, 2022 – PHASTAR, a global specialist biometrics...
Read MorePosted by Samedan Ltd | Jun 29, 2022 | Uncategorized
London, UK and Durham, NC – June 29, 2022 – PHASTAR, a global specialist biometrics...
Read MorePosted by Samedan Ltd | Mar 29, 2022 | Uncategorized
SOUTHBOROUGH, MA – 29 March 2022 – Veristat, a scientific-minded
global clinical research organization (CRO), announced today the
formalization of its Strategic Resourcing solution to offer clients the
delivery of clinical development and regulatory expertise options fully
tailored to their needs. Clients now have access to difficult-to-find
experts dedicated to a specific requirement or function to meet their
objectives and timelines.
Posted by Samedan Ltd | Mar 7, 2022 | Uncategorized
SOUTHBOROUGH, MA – 7 March 2022 – Veristat, a scientific-minded
global clinical research organization (CRO), announced today the
expansion and strengthening of its service capabilities by acquiring SFL
(Solutions for Life Sciences). With headquarters in Basel, Switzerland
and several European affiliates, SFL brings unique capabilities and a
highly credentialed team to support a growing number of biotech,
pharmaceutical and medtech companies.
Posted by Samedan Ltd | Feb 11, 2022 | Uncategorized
BERLIN, Germany, February 11, 2022 / B3C newswire / — ProBioGen
announces a multi-product commercial license agreement with AstraZeneca
to use the GlymaxX technology.
